Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer|September 24, 2004
Autoregulation of the N-myc gene is operative in neuroblastoma and involves histone deacetylase 2Marianne K H Kim, William L Carroll
Molecular Cancer Research : MCR|July 23, 2008
WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppressionDebra J Morrison, Marianne K H Kim, Windy Berkofsky-Fessler, et al.
Virology|September 3, 2003
Isolation of a peptide inhibitor of human rhinovirusMark A Poritz, Sharon Malmstrom, Amy Schmitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 25, 2009
An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1Marianne K-H Kim, Thomas J McGarry, Pilib O Broin, et al.
Neoplasia (New York, N.Y.)|January 31, 2008
A pathologic link between Wilms tumor suppressor gene, WT1, and IFI16Marianne K-H Kim, Jacqueline M Mason, Chi-Ming Li, et al.
Cancer|August 12, 2003
Identification of genes that are regulated transcriptionally by Myc in childhood tumorsElizabeth A Raetz, Marianne K H Kim, Philip Moos, et al.
Molecular Biology of the Cell|August 20, 2010
Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase CSimge Akbulut, Alagarsamy L Reddi, Priya Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 6, 2010
Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617FWindy Berkofsky-Fessler, Monica Buzzai, Marianne K-H Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2012
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cellsMeng-Tzu Weng, Jih-Hsiang Lee, Shu-Chen Wei, et al.
Blood|June 24, 2009
Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignanciesTamer E Fandy, James G Herman, Patrick Kerns, et al.
Pageof 1